Voyager Therapeutics
VYGR
VYGR
125 hedge funds and large institutions have $569M invested in Voyager Therapeutics in 2018 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 49 increasing their positions, 29 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
16% more funds holding
Funds holding: 108 → 125 (+17)
12% more capital invested
Capital invested by funds: $509M → $569M (+$60.1M)
6.01% more ownership
Funds ownership: 84.03% → 90.04% (+6%)
Holders
125
Holding in Top 10
3
Calls
$1.08M
Puts
$683K
Top Buyers
| 1 | +$16.4M | |
| 2 | +$14.3M | |
| 3 | +$10.6M | |
| 4 |
AC
Armistice Capital
New York
|
+$8.44M |
| 5 |
State Street
Boston,
Massachusetts
|
+$8.42M |
Top Sellers
| 1 | -$29.3M | |
| 2 | -$10.6M | |
| 3 | -$4.69M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.71M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$2.38M |